Search details
1.
Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.
Medicina (Kaunas)
; 50(4): 197-203, 2014.
Article
in English
| MEDLINE | ID: mdl-25458955
2.
Harnessing ctDNA in Advanced Melanoma: A Promising Tool for Informed Clinical Decisions.
Cancers (Basel)
; 16(6)2024 Mar 18.
Article
in English
| MEDLINE | ID: mdl-38539531
3.
Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective-prospective cohort multicentre study.
J Cancer Res Clin Oncol
; 149(10): 6979-6988, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36847839
4.
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment.
Eur J Cancer
; 138: 99-108, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32871527
5.
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II).
Melanoma Res
; 30(3): 261-267, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31895752
6.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).
Clin Colorectal Cancer
; 16(2): 103-114.e3, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28038865
7.
[Combined treatment of esophageal cancer: a review]. / Stemples vezio kompleksinis gydymas (apzvalga).
Medicina (Kaunas)
; 40 Suppl 1: 161-5, 2004.
Article
in Lt
| MEDLINE | ID: mdl-15079129
8.
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel.
Wien Klin Wochenschr
; 122(11-12): 368-79, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20549373
Results
1 -
8
de 8
1
Next >
>>